These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8429488)

  • 1. Hygroscopic stability and dissolution properties of spray-dried solid dispersions of furosemide with Eudragit.
    Otsuka M; Onoe M; Matsuda Y
    J Pharm Sci; 1993 Jan; 82(1):32-8. PubMed ID: 8429488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of Furosemide-Eudragit controlled release systems.
    Aceves JM; Cruz R; Hernandez E
    Int J Pharm; 2000 Feb; 195(1-2):45-53. PubMed ID: 10675682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorphism and physicochemical stability of spray-dried frusemide.
    Matsuda Y; Otsuka M; Onoe M; Tatsumi E
    J Pharm Pharmacol; 1992 Aug; 44(8):627-33. PubMed ID: 1359084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
    Dontireddy R; Crean AM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of extended release coevaporates and coprecipitates of promethazine HCl with acrylic polymers: formulation considerations.
    Dahiya S; Pathak K; Sharma R
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):504-8. PubMed ID: 18379098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.
    Pignatello R; Ferro M; Puglisi G
    AAPS PharmSciTech; 2002; 3(2):E10. PubMed ID: 12916947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate.
    Higashi K; Hayashi H; Yamamoto K; Moribe K
    Int J Pharm; 2015 Oct; 494(1):9-16. PubMed ID: 26253374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
    Paudel A; Loyson Y; Van den Mooter G
    J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.
    Adebisi AO; Kaialy W; Hussain T; Al-Hamidi H; Nokhodchi A; Conway BR; Asare-Addo K
    Colloids Surf B Biointerfaces; 2016 Oct; 146():841-51. PubMed ID: 27451373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of some acrylic polymers on dissolution of celecoxib solid dispersion formulations.
    Maghsoodi M; Nokhodchi A; Pourasghari Azar H
    Pharm Dev Technol; 2021 Sep; 26(7):788-796. PubMed ID: 34159879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.